AstraZeneca on Thursday touted Phase III data regarding its investigational inhibitor gefurulimab meeting its primary ...
US anti-virals giant Gilead Sciences late yesterday announced its third quarter 2025 results of operations, reporting total ...
King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...
The European Medicines Agency’s Pharmacovigilance Risk Committee (PRAC) has agreed on a direct healthcare professional communication (DHPC) to remind healthcare professionals that extreme caution ...
The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...
South Korea-based Celltrion today announced that the US Food and Drug Administration (FDA) has designated Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) as interchangeable biosimilars to the ...
The top 20 global biopharmaceutical companies saw their combined market capitalization rise 4% in the third quarter of 2025 ...
US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...
German family-owned pharma major Boehringer Ingelheim has licensed a pre-clinical program from Japan’s Kyowa Kirin to develop ...
Merck & Co (NYSE: MRK) posted third-quarter 2025 revenue of $17.3 billion, up 4% year over year, while adjusted earnings rose ...
Swiss pharma major Roche (ROG: SIX) has entered a global exclusive licensing agreement with China’s Qyuns Therapeutics for ...
China’s R&D and manufacturing services provider WuXi AppTec has reached agreement for Hillhouse Investment Management to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback